Literature DB >> 8599869

Cross-resistance and collateral sensitivity to natural product drugs in cisplatin-sensitive and -resistant rat lymphoma and human ovarian carcinoma cells.

H Parekh1, H Simpkins.   

Abstract

The cytotoxicity of mitotic spindle poisons, vinca alkaloids and the anthracycline, adriamycin, against cisplatin-sensitive and -resistant rat lymphoma and human ovarian carcinoma cell lines was investigated. Interestingly, it was found that all cell lines were more sensitive to the mitotic spindle poisons, vincristine and vinblastine. Adriamycin was the least effective and taxol had intermediate activity. The Walker rat lymphoma cell line resistant to cisplatin (WR) exhibited the multiple drug resistance phenotype since it showed collateral resistance to all drugs (ranging from twofold to taxol, colcemid and colchicine and sixfold to the vinca alkaloids). Verapamil potentiated the cytotoxic activity of adriamycin and vincristine in a striking fashion with the Walker cells. P-glycoprotein was found to be present in the plasma membranes of the Walker cells with approximately a 2.5-fold increase in the WR as compared to the sensitive (WS) cells. Glutathione levels were elevated in all of the cisplatin-resistant cell lines when compared to the cisplatin-sensitive parental cell lines. A profound effect of buthionine sulfoximine pretreatment on adriamycin cytotoxicity was observed. Glutathione S-transferase (pi) was present in all the human cell lines but the WS cells had markedly lower levels (almost negligible) when compared to the WR cells. These observations imply that cisplatin-resistant cells may be more sensitive to mitotic spindle poisons and vinca alkaloids, irrespective of the mechanism of platinum resistance, and that the cytotoxicity of vinca alkaloids could be further modulated by verapamil, irrespective of the presence or absence of P-glycoprotein.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8599869     DOI: 10.1007/s002800050412

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  32 in total

1.  A morphological and phenotypic analysis of Walker 256 cells.

Authors:  H Simpkins; J M Lehman; J E Mazurkiewicz; B H Davis
Journal:  Cancer Res       Date:  1991-02-15       Impact factor: 12.701

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  The Walker 256 carcinoma: a cell type inherently sensitive only to those difunctional agents that can form DNA interstrand crosslinks.

Authors:  R J Knox; D A Lydall; F Friedlos; C Basham; C J Rawlings; J J Roberts
Journal:  Mutat Res       Date:  1991-11       Impact factor: 2.433

4.  Glutathione and glutathione linked enzymes in human small cell lung cancer cell lines.

Authors:  R Sharma; S S Singhal; S K Srivastava; K K Bajpai; E P Frenkel; S Awasthi
Journal:  Cancer Lett       Date:  1993-12-10       Impact factor: 8.679

5.  Glutathione-mediated modulation of tetraplatin activity against sensitive and resistant tumor cells.

Authors:  Y Kido; A R Khokhar; Z H Siddik
Journal:  Biochem Pharmacol       Date:  1994-04-29       Impact factor: 5.858

6.  Differential potentiation of alkylating and platinating agent cytotoxicity in human ovarian carcinoma cells by glutathione depletion.

Authors:  P A Andrews; M P Murphy; S B Howell
Journal:  Cancer Res       Date:  1985-12       Impact factor: 12.701

7.  In vitro modulation of cisplatin accumulation in human ovarian carcinoma cells by pharmacologic alteration of microtubules.

Authors:  R D Christen; A P Jekunen; J A Jones; F Thiebaut; D R Shalinsky; S B Howell
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

Review 8.  Clinical trials of agents that reverse multidrug resistance. A literature review.

Authors:  M Raderer; W Scheithauer
Journal:  Cancer       Date:  1993-12-15       Impact factor: 6.860

9.  Identification of a membrane glycoprotein overexpressed in murine lymphoma sublines resistant to cis-diamminedichloroplatinum(II).

Authors:  K Kawai; N Kamatani; E Georges; V Ling
Journal:  J Biol Chem       Date:  1990-08-05       Impact factor: 5.157

10.  Levels of glutathione S transferase pi mRNA in human lung cancer cell lines correlate with the resistance to cisplatin and carboplatin.

Authors:  K Nakagawa; J Yokota; M Wada; Y Sasaki; Y Fujiwara; M Sakai; M Muramatsu; T Terasaki; Y Tsunokawa; M Terada
Journal:  Jpn J Cancer Res       Date:  1988-03
View more
  8 in total

1.  Regulation of keratin and integrin gene expression in cancer and drug resistance.

Authors:  N Daly; P Meleady; D Walsh; M Clynes
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

2.  Resistance to platinum-based chemotherapy in lung cancer cell lines.

Authors:  Jianli Chen; Nashwa Emara; Charalambos Solomides; Hemant Parekh; Henry Simpkins
Journal:  Cancer Chemother Pharmacol       Date:  2010-02-21       Impact factor: 3.333

Review 3.  Cross-Resistance Among Sequential Cancer Therapeutics: An Emerging Issue.

Authors:  Rossella Loria; Patrizia Vici; Francesca Sofia Di Lisa; Silvia Soddu; Marcello Maugeri-Saccà; Giulia Bon
Journal:  Front Oncol       Date:  2022-06-23       Impact factor: 5.738

Review 4.  Is resistance useless? Multidrug resistance and collateral sensitivity.

Authors:  Matthew D Hall; Misty D Handley; Michael M Gottesman
Journal:  Trends Pharmacol Sci       Date:  2009-09-15       Impact factor: 14.819

5.  In vitro Development of Chemotherapy and Targeted Therapy Drug-Resistant Cancer Cell Lines: A Practical Guide with Case Studies.

Authors:  Martina McDermott; Alex J Eustace; Steven Busschots; Laura Breen; John Crown; Martin Clynes; Norma O'Donovan; Britta Stordal
Journal:  Front Oncol       Date:  2014-03-06       Impact factor: 6.244

6.  Collateral responses to classical cytotoxic chemotherapies are heterogeneous and sensitivities are sparse.

Authors:  Simona Dalin; Beatrice Grauman-Boss; Douglas A Lauffenburger; Michael T Hemann
Journal:  Sci Rep       Date:  2022-03-31       Impact factor: 4.996

7.  Resistance to paclitaxel in a cisplatin-resistant ovarian cancer cell line is mediated by P-glycoprotein.

Authors:  Britta Stordal; Marion Hamon; Victoria McEneaney; Sandra Roche; Jean-Pierre Gillet; John J O'Leary; Michael Gottesman; Martin Clynes
Journal:  PLoS One       Date:  2012-07-11       Impact factor: 3.240

8.  Glutathione S-transferase P1 (GSTP1) directly influences platinum drug chemosensitivity in ovarian tumour cell lines.

Authors:  L Sawers; M J Ferguson; B R Ihrig; H C Young; P Chakravarty; C R Wolf; G Smith
Journal:  Br J Cancer       Date:  2014-07-10       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.